Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who may be sensitive to certain metals or bone cement. The Persona SoluTion ...
-- New Porous Iteration of Anatomic Keeled Tibia Designed to Deliver Stable Initial and Biological Fixation Together with the Clinically Proven Benefits of the Persona Knee System -- "With an ...
WARSAW, Ind., and ZURICH, Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision ...
Zimmer Biomet Holdings ((ZBH)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Zimmer Biomet announced FDA clearance of its Persona ...
Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe technology. It is an updated version of the ROSA Knee system that helps surgeons ...
Please provide your email address to receive an email when new articles are posted on . Zimmer Biomet received FDA premarket approval for its Oxford cementless partial knee replacement implant. The ...
WARSAW, Ind., Feb. 25, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it will unveil new clinical and operational data and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results